Cargando…

Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation

Both nanostructure and multivalency enhance the biological activities of antimicrobial peptides (AMPs), whose mechanism of action is cooperative. In addition, the efficacy of a particular AMP should benefit from a steady concentration at the local place of action and, therefore, from a slow release...

Descripción completa

Detalles Bibliográficos
Autores principales:	Serna, Naroa, López-Laguna, Hèctor, Aceituno, Patricia, Rojas-Peña, Mauricio, Parladé, Eloi, Voltà-Durán, Eric, Martínez-Torró, Carlos, Sánchez, Julieta M., Di Somma, Angela, Carratalá, Jose Vicente, Livieri, Andrea L., Ferrer-Miralles, Neus, Vázquez, Esther, Unzueta, Ugutz, Roher, Nerea, Villaverde, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674355/ https://www.ncbi.nlm.nih.gov/pubmed/38004610 http://dx.doi.org/10.3390/pharmaceutics15112632

Ejemplares similares

The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles
por: Voltà-Durán, Eric, et al.
Publicado: (2022)

Biofabrication of functional protein nanoparticles through simple His-tag engineering
por: López-Laguna, Hèctor, et al.
Publicado: (2021)

Ion-dependent slow protein release from in vivo disintegrating micro-granules
por: Álamo, Patricia, et al.
Publicado: (2021)

The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
por: Sánchez, Julieta María, et al.
Publicado: (2022)

An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials
por: Parladé, Eloi, et al.
Publicado: (2022)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
por: Serna, Naroa, et al.
Publicado: (2021)

Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials
por: Sánchez-García, Laura, et al.
Publicado: (2021)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells
por: Barguilla, Irene, et al.
Publicado: (2022)

In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics
por: Carratalá, Jose V., et al.
Publicado: (2020)

Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019)

Recombinant Proteins for Assembling as Nano- and Micro-Scale Materials for Drug Delivery: A Host Comparative Overview
por: Corchero, José Luis, et al.
Publicado: (2023)

Enhanced recombinant protein capture, purity and yield from crude bacterial cell extracts by N-Lauroylsarcosine-assisted affinity chromatography
por: Carratalá, Jose Vicente, et al.
Publicado: (2023)

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
por: Álamo, Patricia, et al.
Publicado: (2020)

Recombinant vaccines in 2022: a perspective from the cell factory
por: de Pinho Favaro, Marianna Teixeira, et al.
Publicado: (2022)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins
por: Álamo, Patricia, et al.
Publicado: (2023)

Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012)

Engineered Biological Entities for Drug Delivery and Gene Therapy: Protein Nanoparticles
por: Domingo-Espín, Joan, et al.
Publicado: (2011)

Title: insoluble proteins catch heterologous soluble proteins into inclusion bodies by intermolecular interaction of aggregating peptides
por: Carratalá, Jose Vicente, et al.
Publicado: (2021)

Functional inclusion bodies produced in the yeast Pichia pastoris
por: Rueda, Fabián, et al.
Publicado: (2016)

Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
por: Núñez, Yáiza, et al.
Publicado: (2023)

Selecting Subpopulations of High-Quality Protein Conformers among Conformational Mixtures of Recombinant Bovine MMP-9 Solubilized from Inclusion Bodies
por: Carratalá, Jose Vicente, et al.
Publicado: (2021)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Bacterial cell factories for recombinant protein production; expanding the catalogue
por: Ferrer-Miralles, Neus, et al.
Publicado: (2013)

An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination
por: Pallarès, Victor, et al.
Publicado: (2020)

GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
por: Sala, Rita, et al.
Publicado: (2022)

CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
por: Unzueta, Ugutz, et al.
Publicado: (2022)

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy
por: Aviñó, Anna, et al.
Publicado: (2019)

In Vivo Molecular Responses of Fast and Slow Muscle Fibers to Lipopolysaccharide in a Teleost Fish, the Rainbow Trout (Oncorhynchus mykiss)
por: Magnoni, Leonardo J., et al.
Publicado: (2015)

Microbial factories for recombinant pharmaceuticals
por: Ferrer-Miralles, Neus, et al.
Publicado: (2009)

Side effects of chaperone gene co-expression in recombinant protein production
por: Martínez-Alonso, Mónica, et al.
Publicado: (2010)

Protein Nanoparticles Made of Recombinant Viral Antigens: A Promising Biomaterial for Oral Delivery of Fish Prophylactics
por: Thwaite, Rosemary, et al.
Publicado: (2018)

Recombinant pharmaceuticals from microbial cells: a 2015 update
por: Sanchez-Garcia, Laura, et al.
Publicado: (2016)

Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms
por: Torrealba, Débora, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bns00gn3ap8od9e3uddnnok3jo